Neuroprotective effect of exogenous melatonin on dopaminergic neurons of the substantia nigra in ovariectomized rats

Iranian Biomedical Journal

Volumn 15, Issue 1-2, 2011, Pages 44-50

  Mehraein, Fereshteh ^a   Talebi, Reza ^b   Jameie, Behnamedin ^a   Joghataie, Mohammad Taghi ^a   Madjd, Zahra ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dopaminergic neurons (DA); Exogenous melatonin; Morphometric analysis; Ovariectomized rat; Substantia nigra

Indexed keywords

MELATONIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL STRUCTURE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; ESTROGEN DEFICIENCY; FEMALE; IMMUNOCOMPETENT CELL; NERVE CELL NECROSIS; NEUROPROTECTION; NISSL STAINING; NONHUMAN; RAT; SUBSTANTIA NIGRA;

ANIMALS; CELL COUNT; DOPAMINE; FEMALE; HUMANS; MELATONIN; NEURONS; NEUROPROTECTIVE AGENTS; NISSL BODIES; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; RATTUS;

EID: 79959913467     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Juraska, J.M., Wilson, C.J. and Groves, P.M. (1970) The substantia nigra of the rat: A golgi study. J. Comp. Neurol. 172: 585-600.
2. Jeyasingham, R.A., Baird, A.L., Meldrum, A. and Dunnett, S.B. (2001) Differential effects of unilateral striatal and nigrostriatal lesion on grip strength, skilled paw reaching a drug induced rotation in the rat. Brain. Res Bull. 55: 541-548.
3. Hendou, G., Chasserot Golaz, S., Kemmel, V., Gobaille, S., Roussel, G., Artault, J.C., Andriamampandry, C., Aunis, D. and Maitre, M. (2000) Immunohistochemical studies of the localization of neurons containing the enzyme that synthesizes dopamine, GABA or γ hydroxybutyrate in the rat substantia nigra and striatum. J. Comp. Neurol. 426: 549-560.
4. Mayeux, R., Denaro, J., Hemenegildo, N., Marder, K., Tang, M.X., Cote, L.J. and Stern, Y. (1992) A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch. Neurol. 49: 492-497.
5. Leranth, C., Roth, R.H., Elsworth, J.D., Naftolin, F., Horvath, T.L. and Redmond DE. Jr. (2000) Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: Implications for Parkinson's disease and memory. J. NeuroSci. 20: 8604-8609.
6. Ross, M.E., Reis, D.J. and Joh, T.H. (1981). Monoclonal antibodies to tyrosine hydroxylase: Production and characterization. Brain Res. 208: 493-498.
7. Eisen, A., Lubinski, J., Gronwald, J., Moller, P., Lynch, H.T., Klijn, N., Sing, C.K., Neuhausen, S.L., Gilbert, L., Ghaderian, P. et al. (2008). Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. J. Natl. Cancer Inst. 100: 1361-1367.
8. Cramer, D.W. and Knapp, R.C. (1979) Review of epidemiologic studies of endometrial cancer and exogenous estrogen. Obstet. Gynecol. 54: 521-526.
9. Lacey, J.V., Mink, P.J., Lubin, J.H., Sherman, M.E., Trisi, R., Hartge, P., Schatzkin, A. and Schairer, C. (2002) Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA. 288: 334-341.
10. UZ, T., Arsalan, A.D., Kurtuncu, M., Imbesi, M., Akhisaroglu, M., Dwivedi, Y., Pandey, G.N. and Manev, H. (2005) The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system. Brain Res. Mol. Brain Res. 136: 45-53.
11. Reiter, R.J., Tan, D.X., Manchester, L.C. and Tamura, H. (2007) Melatonin defeat neurally derived free radicals and reduces the associated neuromorphological and neurobehavioral damage. J. Physiol. Pharmacol. 6: 5-22.
12. Kilic, E., Kilic, U., Bacigaluppi, M., Guo, Z., Ben Abdallah, N.M., Wolfer, D.P., Reiter, R.J., Hermann, D.M. and Bassetti, C.L. (2008) Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. J. Pineal. Res. 45: 142-148.
13. Sharma, R., McMillan, C.R., Tenn, C.C. and Niles, L.P. (2006) Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease. Brain Res. 1068: 230-236.
14. Manda, K., Ueno, M. and Anzai, K. (2008) Space radiation-induced inhibition of neurogenesis in the hippocampal dentate gyrus and memory impairment in mice: Ameliorative potential of the melatonin metabolite, AFMK. J. Pineal. Res. 45: 430-438.
15. Reiter, R.J. (1991) Melatonin: That ubiquitous by acting pineal hormone. New Physiol. Sci. 6: 223-227.
16. Paxinos, G. and Watson, C. (1998) The rat brain in the stereotaxic coordinates. New York, Academic Press, San Diego, USA.
17. Post, A., Crochemore, C., Uhr, M., Holsboer, F. and Behl, C. (2000) Differential induction of NF-KB activity and neural cell death by antidepressants in vitro. Eur. J. Neurosci. 12: 4331-4337.
18. Hashimoto, T., Yonetani, M. and Nakamura, H. (2003) Selective Brain Hypothermia protects against hypoxia-Ischemic injury in newborn rats by reducing hydroxyl radical production. Kobe J. Med. Sci. 49: 83-91.
19. Sherwin, B.B. and Henry, J.F. (2008) Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: A critical review. Front Neuroendocrinol. 29: 88-113.
20. Wise, P.M. (2006) Estrogen therapy: Does it help or hurt the adult and aging brain? Insights derived from animal models. Neuroscience 138: 831-835.
21. D'Astous, M., Morissette, M. and Di Paolo, T. (2004) Effect of estrogen receptor agonists treatment in MPTP mice: Evidence of neuroprotection by an ER alpha agonist. Neuropharmacology 47:1180-1188.
22. Currie, L.J., Harrison, M.B., Trugman, J.M., Bennett, J.P. and Wooten, G.F. (2004) Postmenopausal estrogen use effects risk for Parkinson disease. Arch Neurol. 61: 886-888.
23. Ragonese, P., D'Amelio, M., Salemi, G., Aridon, P., Gammino, M., Epifanio, A., Morgante, L. and Savettieri, G. (2004) Risk of Parkinson disease in women: Effect of reproductive characteristics. Neurology 62: 2010-2014.
24. Gardiner, S.A., Morrison, M.F., Mozley, P.D., Mozley, L.H., Brensinger, C., Bilker, W., Newberg, A. and Battistini, M. (2004) Piolt study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women. Am. J. Geriatr. Psychiatry 12: 621-630.
25. Tripanichkul, W., Sripanichkulchai, K. and Finkelstein, D.I. (2006) Estrogen down regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication. Brain Res. 1084: 28-37.
26. Shughrue, P.J. (2004) Estrogen attenuates the MPTPinduced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERalpha and ERbeta). Exp. Neurol. 190: 468-477.
27. Rodrigues, C., Mayo, J.C., Saniz, R.M., Antolin, I., Herrera, F., Martin, V. and Reiter, R.J. (2003) Regulation of antioxidant enzymes: A significant role for melatonin. J. Pineal. Res. 36: 1-9.
28. Srinivasan, V. (2002) Melatonin oxidative stress and neurodegenerative disease. Indian J. Exp. Biol. 40: 668-679.
29. Benitez-King, G., Ramirez-Rodriguez, G., Ortiz, L. and Meza, L. (2004) The neural cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia. Curr. Drug Targets CNS Neurol. Disord. 3: 515-533.
30. Antolin, I., Mayo, J.C., Saniz, R.M., del Brio Mde, I., Herrera, F., Martin, V. and Rodrigues, C. (2002) Protective effect of melatonin in a chronic experimental model of Parkinson's disease. Brain Res. 943: 163-173.
31. McMillan, C.R., Sharma, R., Ottenhof, T. and Niles, L.P. (2007) Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells. Neurosci Lett. 419: 202-206.
32. Venero, J.L., Absi, E.H., Cano, J. and Machado, A. (2002) Melatonin induces tyrosine hydroxylase mRNA expression in the ventral mesencephalon but not in the hypothalamus. J. Pineal. Res. 32: 6-14.
33. Gaspar, P., Berger, B., Feburet, A., Vigny, A., Krieger-poulet, M. and Borrivoltattorni, C. (1987) Tyrosine hydroxylase-immunoreactive neurons in the human cerebral cortex: A novel catecholaminergic group. Neurosci. Lett. 80: 257-262.
34. Hornung, J.P., Tork. I and de Tribolet, N. (1989) Morphology of tyrosine hydroxylase immunoreactive neurons in the human cerebral cortex. Exp. Brain Res. 76: 12-20.
35. Mitrofanis, J. (1992) Calbindin immunoreactivity in a subset of cat thalamic reticular neurons. J. Neurocytol. 21: 494-505.
36. Fallon, J.H. and Loughlin, S.E. (1982) Monoamine innervation of the forebrain: Collateralization. Brain Res Bull. 9: 295-307.